Show simple item record

dc.contributor.authorBalaam, Sarah
dc.contributor.authorBailey, Tom G
dc.contributor.authorAnderson, Debra
dc.contributor.authorRetell, James
dc.contributor.authorMcCarthy, Alexandra L
dc.date.accessioned2021-07-29T04:45:40Z
dc.date.available2021-07-29T04:45:40Z
dc.date.issued2021
dc.identifier.issn0162-220X
dc.identifier.doi10.1097/NCC.0000000000000956
dc.identifier.urihttp://hdl.handle.net/10072/406475
dc.description.abstractBACKGROUND: There is evidence that drinking alcohol increases the risk of recurrent breast cancer. It is unclear whether Australian women with breast cancer are aware of this evidence or modify their alcohol intake accordingly. OBJECTIVE: This article reports a secondary analysis of data from the Women's Wellness after Cancer Program (WWACP) randomized controlled trial (N = 351). The WWACP aimed to enhance quality of life and reduce chronic disease risk in women previously treated for cancer through lifestyle modification. Here we provide the alcohol-related data from the study's breast cancer participants (n = 269). We analyzed baseline alcohol consumption, the variables associated with alcohol intake, and intervention effect on intake at weeks 12 (end of intervention) and 24 (to determine sustainability). INTERVENTIONS/METHODS: Measures included the Dietary Questionnaire for Epidemiological Studies, Short Form-36, International Physical Activity Questionnaire, Green Climacteric Scale, Pittsburgh Sleep Quality Index, and Center for Epidemiologic Studies Depression Scale. RESULTS: Most participants practiced safe alcohol consumption. Among drinkers, drinking caffeine, smoking, emotional and physical role limitations, and greater discomfort with vasomotor symptoms were associated with increased intake. Relative to baseline, alcohol consumption decreased from 5.22 g/d to 4.18 g/d in the intervention group, whereas consumption increased among control subjects at 12 weeks. No difference between groups was observed at week 24. CONCLUSION: The intervention was associated with less alcohol intake at week 12 among drinkers, but this reduction was not sustained at the 24-week follow-up. IMPLICATIONS FOR PRACTICE: Future iterations of the WWACP will emphasize stronger messaging and supports regarding alcohol consumption after breast cancer treatment.
dc.description.peerreviewedYes
dc.languageeng
dc.publisherOvid Technologies (Wolters Kluwer Health)
dc.relation.ispartofjournalCancer Nursing
dc.subject.fieldofresearchOncology and carcinogenesis
dc.subject.fieldofresearchNursing
dc.subject.fieldofresearchcode3211
dc.subject.fieldofresearchcode4205
dc.titleAlcohol and Breast Cancer: Results From the Women's Wellness After Cancer Program Randomized Controlled Trial
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationBalaam, S; Bailey, TG; Anderson, D; Retell, J; McCarthy, AL, Alcohol and Breast Cancer: Results From the Women's Wellness After Cancer Program Randomized Controlled Trial, Cancer Nursing, 2021
dc.date.updated2021-07-27T03:18:19Z
gro.description.notepublicThis publication has been entered as an advanced online version in Griffith Research Online.
gro.hasfulltextNo Full Text
gro.griffith.authorBalaam, Sarah
gro.griffith.authorMcCarthy, Sandie L.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record